In This Article:
- By insider
Chairman, CEO of Henry Schein Inc (HSIC) Stanley M Bergman sold 69,000 shares of HSIC on 12/07/2018 at an average price of $86.32 a share. The total sale was $6 million.
Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics. Henry Schein Inc has a market cap of $12.98 billion; its shares were traded at around $85.16 with a P/E ratio of 33.13 and P/S ratio of 1.00. Henry Schein Inc had annual average EBITDA growth of 9.90% over the past ten years. GuruFocus rated Henry Schein Inc the business predictability rank of 5-star.
-
Warning! GuruFocus has detected 3 Warning Signs with BUD. Click here to check it out.
-
The intrinsic value of HSIC
CEO Recent Trades:
-
Chairman, CEO Stanley M Bergman sold 69,000 shares of HSIC stock on 12/07/2018 at the average price of $86.32. The price of the stock has decreased by 1.34% since.
CFO Recent Trades:
-
EVP, CFO Steven Paladino sold 21,110 shares of HSIC stock on 12/03/2018 at the average price of $90.06. The price of the stock has decreased by 5.44% since.
Directors and Officers Recent Trades:
-
CCO&Pres. Corp. Com. Dev. Grp. David Mckinley sold 8,321 shares of HSIC stock on 11/30/2018 at the average price of $88.77. The price of the stock has decreased by 4.07% since.
For the complete insider trading history of HSIC, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 3 Warning Signs with BUD. Click here to check it out.
-
The intrinsic value of HSIC